{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:46:39Z","timestamp":1789663599249,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["IC00I0\\u2013227558"],"award-info":[{"award-number":["IC00I0\\u2013227558"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography A"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.chroma.2025.465972","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T06:17:41Z","timestamp":1744870661000},"page":"465972","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Systematic comparison of wide pore size exclusion chromatography columns for the characterization of gene therapy products"],"prefix":"10.1016","volume":"1752","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-2338-8954","authenticated-orcid":false,"given":"Mathias","family":"Buff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Goyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Elger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Ruppert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Haindl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7883-5823","authenticated-orcid":false,"given":"Davy","family":"Guillarme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chroma.2025.465972_bib0001","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41392-023-01589-z","article-title":"Recent advances in targeting the \u201cundruggable\u201d proteins: from drug discovery to clinical trials","volume":"8","author":"Xie","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.chroma.2025.465972_bib0002","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.3390\/ph16101416","article-title":"Current State of Human gene therapy: approved products and vectors","volume":"16","author":"Shchaslyvyi","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.chroma.2025.465972_bib0003","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3390\/v15030698","article-title":"Viral vectors in gene therapy: where do we stand in 2023?","volume":"15","author":"Lundstrom","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.chroma.2025.465972_bib0004","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-021-00487-6","article-title":"Viral vector platforms within the gene therapy landscape","volume":"6","author":"Bulcha","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.chroma.2025.465972_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120586","article-title":"mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability","volume":"601","author":"Schoenmaker","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.chroma.2025.465972_bib0006","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/2277-9175.98152","article-title":"Viral and nonviral delivery systems for gene delivery","volume":"1","author":"Nayerossadat","year":"2012","journal-title":"Adv. Biomed. Res."},{"key":"10.1016\/j.chroma.2025.465972_bib0007","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.2147\/IJN.S203330","article-title":"Synthesis and characterization of nanometer-sized liposomes for encapsulation and microRNA transfer to breast cancer cells","volume":"14","author":"Lujan","year":"2019","journal-title":"Int. J. Nanomedicine Volume"},{"key":"10.1016\/j.chroma.2025.465972_bib0008","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.omtm.2021.02.010","article-title":"Analytical methods for process and product characterization of recombinant adeno-associated virus-based gene therapies","volume":"20","author":"Gimpel","year":"2021","journal-title":"Mol. Ther. - Methods Clin. Dev."},{"key":"10.1016\/j.chroma.2025.465972_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101309","article-title":"Characterization of AAV vectors: a review of analytical techniques and critical quality attributes","volume":"32","author":"Kontogiannis","year":"2024","journal-title":"Mol. Ther. - Methods Clin. Dev."},{"key":"10.1016\/j.chroma.2025.465972_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2023.117088","article-title":"Chromatographic strategies for the analytical characterization of adeno-associated virus vector-based gene therapy products","volume":"164","author":"Fekete","year":"2023","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.chroma.2025.465972_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.115174","article-title":"Challenges and emerging trends in liquid chromatography-based analyses of mRNA pharmaceuticals","volume":"224","author":"Fekete","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2025.465972_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2025.465724","article-title":"Characterisation and analysis of mRNA critical quality attributes using liquid chromatography based methods","volume":"1745","author":"Webb","year":"2025","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2025.465972_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.464862","article-title":"Size exclusion chromatography of biopharmaceutical products: from current practices for proteins to emerging trends for viral vectors, nucleic acids and lipid nanoparticles","volume":"1722","author":"D\u2019Atri","year":"2024","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2025.465972_bib0014","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jchromb.2018.06.029","article-title":"Unraveling the mysteries of modern size exclusion chromatography - the way to achieve confident characterization of therapeutic proteins","volume":"1092","author":"Goyon","year":"2018","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.chroma.2025.465972_bib0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jchromb.2017.09.027","article-title":"Characterization of 30 therapeutic antibodies and related products by size exclusion chromatography: feasibility assessment for future mass spectrometry hyphenation","volume":"1065\u20131066","author":"Goyon","year":"2017","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.chroma.2025.465972_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.aca.2021.338987","article-title":"The importance of being metal-free: the critical choice of column hardware for size exclusion chromatography coupled to high resolution mass spectrometry","volume":"1183","author":"Murisier","year":"2021","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.chroma.2025.465972_bib0017","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1089\/hum.2022.218","article-title":"Application of size exclusion chromatography with multiangle light scattering in the analytical development of a preclinical stage gene therapy program","volume":"34","author":"Troxell","year":"2023","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.chroma.2025.465972_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2023.464587","article-title":"Fast and efficient size exclusion chromatography of adeno associated viral vectors with 2.5 \u00b5m particle low adsorption columns","volume":"1714","author":"Imio\u0142ek","year":"2024","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2025.465972_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101382","article-title":"Size-exclusion chromatography as a multi-attribute method for process and product characterization of adeno-associated virus","volume":"32","author":"Mulagapati","year":"2024","journal-title":"Mol. Ther. - Methods Clin. Dev."},{"key":"10.1016\/j.chroma.2025.465972_bib0020","doi-asserted-by":"crossref","first-page":"15017","DOI":"10.1021\/acs.analchem.3c02944","article-title":"Separation of plasmid DNA topological forms, messenger RNA, and lipid nanoparticle aggregates using an ultrawide pore size exclusion chromatography column","volume":"95","author":"Goyon","year":"2023","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2025.465972_bib0021","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1021\/acs.analchem.3c05539","article-title":"Comprehensive impurity profiling of mRNA: evaluating current technologies and advanced analytical techniques","volume":"96","author":"Camperi","year":"2024","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2025.465972_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.464756","article-title":"Evaluation of size-exclusion chromatography, multi-angle light scattering detection and mass photometry for the characterization of mRNA","volume":"1719","author":"De Vos","year":"2024","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2025.465972_bib0023","doi-asserted-by":"crossref","first-page":"6254","DOI":"10.3390\/ijms25116254","article-title":"Optimizing messenger RNA analysis using ultra-wide pore size exclusion chromatography columns","volume":"25","author":"D\u2019Atri","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.chroma.2025.465972_bib0024","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0021-9673(00)91616-9","article-title":"Optimization of efficiency in size-exclusion chromatography","volume":"282","author":"Engelhardt","year":"1983","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2025.465972_bib0025","unstructured":"Agilent Technologies application note 5994-7509EN (May 28, 2024) improved wide pore size exclusion chromatography columns for AAV analysis. Avaialble at: https:\/\/www.agilent.com\/cs\/library\/applications\/an-aggregate-analysis-aav-5994-7509en-agilent.pdf. Accessed on February 2025."},{"key":"10.1016\/j.chroma.2025.465972_bib0026","unstructured":"Agilent Technologies application note 5994-6785EN (September 9, 2024) Aggregate Analysis of Adeno-Associated Viruses and Virus-Like Particles in Biopharma using Liquid Chromatography. Avaialble at: https:\/\/www.agilent.com\/cs\/library\/brochures\/og-aav-vlp-aggregate-analysis-5994-6785en-agilent.pdf. Accessed on February 2025."},{"key":"10.1016\/j.chroma.2025.465972_bib0027","unstructured":"Phenomenex application note AN-1175 (February 24, 2024) performance comparison of BiozenTM dSEC-7 SEC column for AAV aggregate analysis. Available at: https:\/\/www.phenomenex.com\/-\/jssmedia\/phxjss\/data\/media\/documents\/an58390124-w.pdf?rev=17930a3763d94bd5ac08ec8f6fd3afda&srsltid=AfmBOopqpJIoVC-tx3VuMte3m3Xvr5iyrkAyQLZQ2f_6Vm1_aYWcGumf. Accessed on February 2025."},{"key":"10.1016\/j.chroma.2025.465972_bib0028","unstructured":"Phenomenex application note AN-1165 (February 226, 2024) adeno-associated virus (AAV) serotype screen using a BiozenTM dSEC-7 size exclusion column. Available at: https:\/\/www.phenomenex.com\/-\/jssmedia\/phxjss\/data\/media\/documents\/an56080923-w.pdf?rev=13896460936447ebadad630f2e56dde7&srsltid=AfmBOoof1KvvAqDMKxCP4ACpkR8WdAQ1mfgfumeF29rgQYNcdC1_oOjV. Accessed on February 2025."},{"key":"10.1016\/j.chroma.2025.465972_bib0029","unstructured":"Thermo-Fisher application note AN003089-EN 0824S (July 26, 2024) size-exclusion chromatography of adeno-associated viruses with the SurePac Bio 550 SEC MDi column. Available at: https:\/\/assets.thermofisher.com\/TFS-Assets\/CMD\/Application-Notes\/an-003089-ccs-sec-column-surepac-aav-an003089-na-en.pdf. Accessed on February 2025."},{"key":"10.1016\/j.chroma.2025.465972_bib0030","unstructured":"Waters Corporation application note 720007969 (June 2023) heightened characterization of AAVs by SEC-MALS with GTxResolve premier BEH SEC 450 \u00c5 2.5 \u03bcm Columns. Available at: https:\/\/www.waters.com\/content\/dam\/waters\/en\/app-notes\/2023\/720007969\/720007969-en.pdf. Accessed on February 2025."},{"key":"10.1016\/j.chroma.2025.465972_bib0031","unstructured":"Waters Corporation application note 720007961 (June 2023) Improved size-exclusion chromatography of adeno-associated viruses (AAVs) with GTxResolve premier BEH SEC 450 \u00c5 2.5 \u03bcm columns. Availalbe at: https:\/\/www.waters.com\/content\/dam\/waters\/en\/app-notes\/2023\/720007961\/720007961-en.pdf. Accessed on February 2025."},{"key":"10.1016\/j.chroma.2025.465972_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.465051","article-title":"Quantitative description of the quality of size exclusion chromatography separations","volume":"1730","author":"Fekete","year":"2024","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2025.465972_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.464726","article-title":"Considering the selectivity of pore size gradient size exclusion chromatography columns","volume":"1718","author":"Fekete","year":"2024","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2025.465972_bib0034","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3390\/pharmaceutics13040586","article-title":"Characterization of recombinant adeno-associated viruses (rAAVs) for gene therapy using orthogonal techniques","volume":"13","author":"Cole","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.chroma.2025.465972_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e07904","article-title":"Extension of hydrodynamic chromatography to DNA fragment sizing and quantitation","volume":"7","author":"Wang","year":"2021","journal-title":"Heliyon"},{"key":"10.1016\/j.chroma.2025.465972_bib0036","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1021\/ac403190a","article-title":"High-resolution hydrodynamic chromatographic separation of large DNA using narrow, bare open capillaries: a rapid and economical alternative technology to pulsed-field gel electrophoresis?","volume":"86","author":"Liu","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2025.465972_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.465075","article-title":"Retention mechanism in combined hydrodynamic and slalom chromatography for analyzing large nucleic acid biopolymers relevant to cell and gene therapies","volume":"1730","author":"Gritti","year":"2024","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2025.465972_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.465487","article-title":"Ultra-high pressure slalom chromatography: application to the characterization of large DNA and RNA samples relevant in cell and gene therapy","volume":"1738","author":"Gritti","year":"2024","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2025.465972_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2025.465691","article-title":"Retention mechanism in slalom chromatography: perspectives on the characterization of large DNA and RNA biopolymers in cell and gene therapy","volume":"1743","author":"Gritti","year":"2025","journal-title":"J. Chromatogr. A"}],"container-title":["Journal of Chromatography A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967325003206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967325003206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T18:04:22Z","timestamp":1762193062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021967325003206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":39,"alternative-id":["S0021967325003206"],"URL":"https:\/\/doi.org\/10.1016\/j.chroma.2025.465972","relation":{},"ISSN":["0021-9673"],"issn-type":[{"value":"0021-9673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic comparison of wide pore size exclusion chromatography columns for the characterization of gene therapy products","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography A","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chroma.2025.465972","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"465972"}}